These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24789170)
1. Tuberculosis in liver transplant recipients: experience of a South Indian liver transplant center. Olithselvan A; Rajagopala S; Vij M; Shanmugam V; Shanmugam N; Rela M Liver Transpl; 2014 Aug; 20(8):960-6. PubMed ID: 24789170 [TBL] [Abstract][Full Text] [Related]
2. Mycobacterium tuberculosis infection in solid organ transplant recipients: experience from a single center in China. Zhang XF; Lv Y; Xue WJ; Wang B; Liu C; Tian PX; Yu L; Chen XY; Liu XM Transplant Proc; 2008 Jun; 40(5):1382-5. PubMed ID: 18589112 [TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcomes of tuberculosis in solid organ transplant recipients. Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494 [TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: A multicentric case-control study in a low-endemic area. Gras J; De Castro N; Montlahuc C; Champion L; Scemla A; Matignon M; Lachâtre M; Raskine L; Grall N; Peraldi MN; Molina JM Transpl Infect Dis; 2018 Oct; 20(5):e12943. PubMed ID: 29890021 [TBL] [Abstract][Full Text] [Related]
6. Liver transplantation without isoniazid prophylaxis for recipients with a history of tuberculosis. Nagai S; Fujimoto Y; Taira K; Egawa H; Takada Y; Kiuchi T; Tanaka K Clin Transplant; 2007; 21(2):229-34. PubMed ID: 17425750 [TBL] [Abstract][Full Text] [Related]
7. Is isoniazid safe for liver transplant candidates with latent tuberculosis? Stucchi RS; Boin IF; Angerami RN; Zanaga L; Ataide EC; Udo EY Transplant Proc; 2012 Oct; 44(8):2406-10. PubMed ID: 23026607 [TBL] [Abstract][Full Text] [Related]
8. Isoniazid treatment to prevent TB in kidney and pancreas transplant recipients based on an interferon-γ-releasing assay: an exploratory randomized controlled trial. Kim SH; Lee SO; Park IA; Kim SM; Park SJ; Yun SC; Jung JH; Shin S; Kim YH; Choi SH; Kim YS; Woo JH; Park SK; Park JS; Han DJ J Antimicrob Chemother; 2015 May; 70(5):1567-72. PubMed ID: 25608587 [TBL] [Abstract][Full Text] [Related]
9. Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period. Sidhu A; Verma G; Humar A; Kumar D Transplantation; 2014 Sep; 98(6):671-5. PubMed ID: 24825525 [TBL] [Abstract][Full Text] [Related]
10. Incidence, Outcomes, and Long-term Immune Response to Tuberculosis in Organ Transplant Recipients. Natori Y; Ferreira VH; Nellimarla S; Husain S; Rotstein C; Humar A; Kumar D Transplantation; 2019 Jan; 103(1):210-215. PubMed ID: 29944616 [TBL] [Abstract][Full Text] [Related]
11. Latent Mycobacterium tuberculosis Infection in Liver Transplant Recipients-Controversies in Current Diagnosis and Management. Rajagopala S; Olithselvan A; Varghese J; Shanmugam N; Rela M J Clin Exp Hepatol; 2011 Jun; 1(1):34-7. PubMed ID: 25755308 [TBL] [Abstract][Full Text] [Related]
12. Tuberculosis in renal transplant recipients: the evidence for prophylaxis. Currie AC; Knight SR; Morris PJ Transplantation; 2010 Oct; 90(7):695-704. PubMed ID: 20647975 [TBL] [Abstract][Full Text] [Related]
13. Isoniazid Prophylaxis for Latent Tuberculosis Infections in Liver Transplant Recipients in a Tuberculosis-Endemic Area. Moon HH; Park SY; Kim JM; Park JB; Kwon CHD; Peck KR; Kim SJ; Lee SK; Joh JW Ann Transplant; 2017 Jun; 22():338-345. PubMed ID: 28579606 [TBL] [Abstract][Full Text] [Related]
14. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Holty JE; Gould MK; Meinke L; Keeffe EB; Ruoss SJ Liver Transpl; 2009 Aug; 15(8):894-906. PubMed ID: 19642133 [TBL] [Abstract][Full Text] [Related]
15. A case of cerebral tuberculosis after liver transplant and literature review. Tunca MZ; Yılmaz Akçay E; Moray G; Özen Ö; Özdemir BH Exp Clin Transplant; 2014 Mar; 12 Suppl 1():117-9. PubMed ID: 24635807 [TBL] [Abstract][Full Text] [Related]
16. Tuberculosis in Egyptian kidney transplant recipients: study of clinical course and outcome. el-Agroudy AE; Refaie AF; Moussa OM; Ghoneim MA J Nephrol; 2003; 16(3):404-11. PubMed ID: 12832742 [TBL] [Abstract][Full Text] [Related]
18. Tuberculosis in renal transplant recipients: a Brazilian center registry. Guida JP; Bignotto Rosane D; Urbini-Santos C; Alves-Filho G; Ribeiro Resende M; Mazzali M Transplant Proc; 2009 Apr; 41(3):883-4. PubMed ID: 19376379 [TBL] [Abstract][Full Text] [Related]
19. Tuberculosis in systemic lupus erythematosus in an endemic area and the role of isoniazid prophylaxis during corticosteroid therapy. Mok MY; Lo Y; Chan TM; Wong WS; Lau CS J Rheumatol; 2005 Apr; 32(4):609-15. PubMed ID: 15801014 [TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis. Singh N; Wagener MM; Gayowski T Transplantation; 2002 Sep; 74(6):892-5. PubMed ID: 12364876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]